Clinical overview
Amniotic fluid is not inert packing — it is a dynamic, fetally-derived medium that protects the cord and limbs, permits symmetrical musculoskeletal growth and lung development, allows fetal swallowing and breathing movements, and buffers infection. Its volume is the visible end-result of an equilibrium between fetal urine production and lung-fluid efflux (the inflows) and fetal swallowing and intramembranous absorption (the outflows). Because that equilibrium is tightly fetally regulated, an abnormal liquor volume is rarely the disease itself; it is a window onto a problem somewhere in the fetal–placental unit. The registrar's task is therefore never simply to label a measurement as "oligo-" or "poly-", but to ask what the abnormal volume is telling you about uteroplacental function, fetal anatomy, fetal swallowing, fetal urine output, or the membranes.
In a South African public-sector setting this is a high-yield, high-frequency problem. Oligohydramnios most often co-travels with the conditions that dominate our maternal and perinatal mortality picture — pre-eclampsia, fetal growth restriction and post-dates pregnancies — and so its detection feeds directly into surveillance and timing-of-delivery decisions made under real resource constraints. Polyhydramnios, less common, raises the question of undiagnosed maternal diabetes (very prevalent and often missed), fetal structural or swallowing anomalies, and — acutely — the risk of cord prolapse and abruption when the membranes rupture against an over-distended uterus. Getting the assessment and the escalation pathway right matters for the baby.
Core knowledge
Amniotic fluid dynamics
From the second trimester onward, fetal urine is the dominant source of amniotic fluid and fetal swallowing the dominant route of removal, with intramembranous absorption across the fetal surface of the placenta and cord providing the final regulatory step. This explains the two great mechanistic families:
- Reduced inflow → oligohydramnios. Anything that lowers fetal urine output: chronic uteroplacental insufficiency (the FGR/pre-eclampsia axis, where preferential blood-flow redistribution spares brain and heart at the kidneys' expense), renal agenesis or dysplasia, or lower-urinary-tract obstruction (posterior urethral valves) where urine is made but cannot reach the amniotic cavity.
- Lost fluid → oligohydramnios via PPROM — membrane rupture is the single commonest cause of reduced liquor in clinical practice and must always be actively excluded.
- Increased inflow or blocked outflow → polyhydramnios. Either the fetus makes too much urine (maternal hyperglycaemia driving fetal osmotic diuresis; recipient twin in twin–twin transfusion syndrome) or it cannot swallow/absorb the fluid (oesophageal atresia, duodenal atresia, neuromuscular or CNS conditions impairing swallowing, severe anaemia/hydrops).
Definitions and thresholds
Volume is estimated sonographically, not measured directly. Two indices are in routine use, and the registrar should know both because the choice between them changes the diagnosis rate:
- Single deepest pocket (SDP / maximum vertical pocket): a clear, cord-free, fetal-part-free vertical column of fluid. Standard teaching: oligohydramnios = SDP < 2 cm; polyhydramnios = SDP > 8 cm.
- Amniotic fluid index (AFI): the sum of the deepest vertical pocket in each of four uterine quadrants. Standard teaching: oligohydramnios = AFI < 5 cm; polyhydramnios (broadly) = AFI > 24–25 cm, with severity often graded (mild/moderate/severe) by increasing AFI.
A key point repeatedly tested: in the third trimester and in labour, the SDP is preferred because, compared with the AFI, it identifies fewer fetuses as oligohydramnios without worsening perinatal outcome — i.e. AFI over-diagnoses and drives more intervention (induction, caesarean) for no demonstrable benefit. Use the SDP as your working index unless local protocol dictates otherwise, and document which index you used.
Anhydramnios is the complete absence of measurable fluid — a different and more ominous category, classically associated with bilateral renal agenesis, early severe PPROM, or end-stage placental failure.
Figure L6.1 — Amniotic-fluid balance, ultrasound thresholds for oligohydramnios and polyhydramnios, and why the single deepest pocket is preferred in late pregnancy and labour.
Why volume matters to the fetus
Prolonged severe oligohydramnios, especially in the second trimester, causes pulmonary hypoplasia (lungs need intraluminal fluid distension to grow) and limb contractures/positional deformities (the Potter sequence when due to renal causes). It also predisposes to cord compression — the mechanism behind the variable decelerations and the higher caesarean rate seen in oligohydramnios in labour. Polyhydramnios over-distends the uterus, raising the risk of preterm labour, malpresentation, cord prolapse at membrane rupture, placental abruption from rapid decompression, and postpartum haemorrhage from uterine atony.
Assessment
The assessment is the engine of management — find the cause, grade the severity, and judge fetal wellbeing.
History
- Gestation and accurate dating (gestational-age-assessment) — defines whether you are facing a viability/pulmonary-hypoplasia problem or a timing-of-delivery problem.
- For suspected oligohydramnios: any gush or persistent watery leak (PPROM), reduced fetal movements (decreased-fetal-movements), features of pre-eclampsia (pre-eclampsia-and-hellp), known FGR or a small symphysis–fundal height.
- For suspected polyhydramnios: rapid abdominal enlargement, breathlessness, maternal diabetes risk or known gestational diabetes, prior anomalous baby, abdominal discomfort.
Examination
- Symphysis–fundal height (large- or small-for-dates), uterine tone, fetal lie and presentation (over-distension favours malpresentation; reduced fluid makes fetal parts unusually easy to palpate).
- Maternal blood pressure and urinalysis (the pre-eclampsia screen).
- If PPROM is suspected: sterile speculum to look for pooling of liquor in the posterior fornix. Avoid digital examination if PPROM is suspected and the woman is not in labour, to limit ascending infection — see preterm-birth-and-pprom.
Investigations
- Ultrasound is central: confirm and grade the volume (SDP/AFI, stating which), then perform a careful structural survey (obstetric-ultrasound). In oligohydramnios specifically look at the fetal kidneys and bladder (presence, echotexture, dilatation) and assess growth — oligohydramnios + FGR is a different and more urgent entity than isolated normal-growth oligohydramnios. In polyhydramnios look for the "double bubble" of duodenal atresia, an absent stomach bubble with polyhydramnios (oesophageal atresia), CNS/spinal lesions, and signs of hydrops (effusions, ascites, skin oedema).
- Umbilical artery Doppler and, where available, MCA Doppler and the cerebroplacental ratio to characterise placental function in any oligohydramnios with growth restriction (ISUOG Doppler standards; intrauterine-growth-restriction, placental-insufficiency-response).
- Maternal glucose testing for all polyhydramnios — a 75 g OGTT/HbA1c per local protocol; undiagnosed diabetes is the commonest identifiable cause.
- Targeted fetal-anaemia / infection work-up where polyhydramnios is unexplained or hydrops is present: MCA peak systolic velocity for anaemia, maternal red-cell antibody screen (rh-isoimmunisation), and consideration of congenital infection.
- Where PPROM is the question, confirm with speculum pooling supplemented by a commercial membrane-rupture test if pooling is equivocal.
Management
Management is determined by cause, gestation and fetal condition, not by the number alone. The first three questions are always: Is this PPROM? Is the fetus growth-restricted/compromised? How premature is this baby?
Oligohydramnios
- Exclude PPROM first. If the membranes have ruptured, the pathway is the PPROM pathway — gestation-dependent latency management, antenatal corticosteroids and consideration of magnesium sulphate for neuroprotection at the appropriate gestations, group-B-strep/erythromycin considerations and surveillance for chorioamnionitis — covered fully under preterm-birth-and-pprom. Do not chase the "low liquor" as a separate problem.
- Oligohydramnios with FGR / abnormal Doppler / pre-eclampsia is a manifestation of placental insufficiency. Manage as growth restriction: intensify surveillance (Doppler, CTG, growth interval), give antenatal corticosteroids if delivery before term is anticipated (RCOG GTG 74), and time delivery on the balance of in-utero risk versus prematurity following FGR principles (intrauterine-growth-restriction, high-risk-pregnancy-risks). Deteriorating Doppler or an abnormal CTG (ctg-interpretation) mandates delivery.
- Isolated oligohydramnios at term with a normally grown fetus, intact membranes and a reassuring CTG: standard teaching favours delivery (induction) at/after term, because continued conservative management at term offers no advantage and reduced fluid raises the risk of cord-compression patterns in labour. Counsel that labour carries a higher chance of variable decelerations and operative delivery, and monitor continuously.
- Second-trimester severe oligohydramnios/anhydramnios carries a guarded prognosis owing to pulmonary hypoplasia and, if renal in origin (e.g. bilateral renal agenesis), is usually lethal — this requires senior fetal-medicine counselling, honest prognostication and shared decision-making rather than reflexive intervention.
- Maternal hydration modestly and transiently raises measured liquor and may be used as an adjunct, but it does not treat the underlying cause; do not let it substitute for diagnosis and appropriate timing of delivery.
Figure L6.2 — Oligohydramnios triage: exclude PPROM, separate placental-insufficiency pregnancies from isolated term low liquor, and escalate severe early anhydramnios for fetal-medicine counselling.
Polyhydramnios
- Treat the cause. Optimise glycaemic control in diabetes (medical-complications-in-pregnancy); investigate and refer structural anomalies and suspected swallowing problems (oesophageal/duodenal atresia) so that delivery is planned where neonatal surgery is available; manage suspected TTTS and fetal anaemia through fetal-medicine pathways (multiple-pregnancy, rh-isoimmunisation).
- Symptom relief: for severe, symptomatic polyhydramnios (maternal respiratory distress, threatened preterm labour) amnioreduction (therapeutic amniocentesis) may be considered in a unit equipped to do it, accepting the risks of abruption, rupture of membranes and infection. Indomethacin can reduce fetal urine output but is generally avoided beyond ~32 weeks because of ductal constriction and oligohydramnios risk; reserve for specialist use under monitoring.
- Plan delivery carefully. Over-distension predisposes to malpresentation, so confirm lie. Anticipate cord prolapse and abruption at the moment of membrane rupture, and anticipate uterine atony and PPH after delivery — have active third-stage management and uterotonics ready (postpartum-haemorrhage).
Emergency drills (unmistakable)
- CORD PROLAPSE at ARM/SROM in polyhydramnios — OBSTETRIC EMERGENCY. Avoid handling the cord; elevate the presenting part (manually or by filling the bladder), place the woman knee–chest or in steep head-down/left-lateral to relieve compression, call for help, and deliver by the fastest safe route — usually immediate caesarean unless full dilatation allows quicker safe vaginal/instrumental birth. (RCOG GTG 50.) When rupturing membranes in a high-head, over-distended uterus, perform a controlled amniotomy with a needle/decompression technique and a hand guarding the presenting part to reduce this risk.
- PLACENTAL ABRUPTION after rapid decompression: sudden pain, bleeding, hard tender uterus, fetal compromise — resuscitate, deliver, and manage as antepartum haemorrhage (antepartum-haemorrhage).
- POSTPARTUM HAEMORRHAGE from atony: the over-distended uterus is a high-risk uterus — anticipate, give a prophylactic uterotonic with active third-stage management, and escalate early (postpartum-haemorrhage).
- CHORIOAMNIONITIS in PPROM-related oligohydramnios: maternal pyrexia, tachycardia, tender uterus, fetal tachycardia, offensive liquor → broad-spectrum antibiotics and delivery, irrespective of gestation.
Figure L6.3 — Polyhydramnios management plan: identify treatable causes, relieve severe symptoms selectively, control membrane rupture and rehearse the cord-prolapse, abruption and atony hazards.
Red flags / pitfalls
- Treating the number, not the cause. "AFI is 4" is a finding, not a diagnosis. The questions are PPROM? FGR/placental insufficiency? anomaly? diabetes? Skipping the structural survey and the placental-function assessment is the classic error.
- Using the AFI in late pregnancy/labour and over-diagnosing oligohydramnios, then intervening (induction/caesarean) without benefit. Prefer the SDP in the third trimester and labour, and always document the index used.
- Missing PPROM because no formal speculum was done, or doing a digital examination in suspected PPROM not in labour and introducing infection.
- Failing to exclude diabetes in polyhydramnios — it is common, frequently asymptomatic, and the single most actionable cause.
- Forgetting the over-distension hazards — not anticipating malpresentation, cord prolapse at rupture, abruption on decompression, and atonic PPH.
- Reflex delivery of severe second-trimester oligohydramnios without fetal-medicine counselling about pulmonary hypoplasia and likely cause/prognosis.
- Equating any low liquor with imminent fetal death — isolated oligohydramnios with normal growth and Doppler is a far better prognosis than oligohydramnios with growth restriction; conflating the two leads either to over-intervention or to under-recognition of the genuinely sick FGR fetus.
- Letting maternal hydration or a single normal CTG substitute for serial assessment in a placental-insufficiency pregnancy.
Evidence anchors
- SA National Integrated Maternal and Perinatal Care Guideline (NDoH, 2024) — the South African obstetric source of truth for surveillance of high-risk pregnancies, PPROM management, and level-of-care referral pathways underpinning the management above.
- RCOG Green-top Guideline No. 31 — Small-for-Gestational-Age and Growth-Restricted Fetus, with ISUOG Doppler standards, for the FGR/placental-insufficiency framework that governs oligohydramnios with growth restriction.
- RCOG Green-top Guideline No. 74 — Antenatal corticosteroids, for steroid administration when preterm delivery is anticipated.
- RCOG Green-top Guideline No. 73 — PPROM ≥24 weeks, for the membrane-rupture pathway that underlies the commonest cause of reduced liquor.
- RCOG Green-top Guideline No. 50 — Umbilical Cord Prolapse, for the cord-prolapse emergency drill.
- NICE NG133 — Hypertension in pregnancy (2019) and NICE NG201 — Antenatal care, for the pre-eclampsia and surveillance context.
- NICE NG229 — Fetal monitoring in labour (2022), for intrapartum CTG interpretation where cord compression complicates oligohydramnios.
- NCCEMD / Saving Mothers (latest triennium) — situates these conditions within SA's leading maternal-death causes (obstetric haemorrhage and hypertension), informing the emphasis on PPH and abruption preparedness.
Note on hedged facts: the SDP/AFI numeric thresholds (SDP <2/>8 cm; AFI <5/>24–25 cm) and the dominance of fetal urine/swallowing in fluid turnover are stated as standard teaching; they are not line-item entries in the verified-sources list and have been written cautiously rather than attached to a specific citation.